ArnonR., and CinaderB.: “Antibodies to enzymes”. In AmosB., Ed. Progress in Immunology: First International Congress of Immunology. pp. 1199–1204. New York, Academic Press, 1971.
2.
BerkowitzB., and SpectorS.: Evidence for active immunity to morphine in mice.Science178: 1290–1292, 1972.
3.
BosmannH. B.: Acetylcholine receptor: I. Identification and biochemical characteristics of a cholinergic receptor of guinea pig cerebral cortex.J. Biol. Chem.247: 130–145, 1972.
4.
BoydW. C.: Fundamentals of Immunology. pp. 305–335. New York, Interscience Publishers, 1966.
5.
BoydW. C.: Fundamentals of Immunology. pp. 43–116. New York, Interscience Publishers, 1966.
6.
BrightmanM. W.: The distribution within the brain of ferritin injected into cerebrospinal fluid compartments: II. Parenchymal distribution.Am. J. Anat.117: 193–219, 1965.
7.
CarrollR. C., EldefrawlM. E., and EdelsteinS. J.: Studies on the structure of the ancetylcholine receptor from Torpedo marmorata.Biochem. Biophys. Res. Commun.55: 864–872, 1973.
8.
CrosbyE. C., HumphreyT., LauerE. W., KappersJ. A., BakerB. L., FoxC. A., GillilanL. A., and ScharenbergK.: Correlative Anatomy of the Nervous System. pp. 380–388 and 432–433. New York, MacMillan, 1962.
9.
CutlerR. W., WattersG. V., and HammerstadJ. P.: The origin and turnover rates of cerebrospinal fluid albumin and gama-globulin in man.J. Neurol. Sci.10: 259–268, 1970.
10.
DayE. D.: “The antibody binding site.” In Advanced Immunochemistry. pp. 144–157. Baltimore, Williams and Wilkins, 1972.
11.
DresserD. W.: Specific inhibition of antibody production: II. Paralysis induced in adult mice by small quantities of protein antigen.Immunology5: 378–388, 1962.
12.
EisenH. N., and PressmanD.: “Antibody structure: combining site.” In AmosB. Ed. Progress in Immunology: First International Congress in Immunology. pp. 1253–1256. New York, Academic Press, 1971.
13.
FesselW. J.: Blood proteins in functional psychoses.Arch. Gen. Psychiatry6: 132–148, 1962.
14.
FreidhoffA. J., and VanWinkleE.: Isolation and characterization of a compound from the urine of schizophrenics.Nature194: 897–898, 1962.
15.
FrohmanC. E., GoodmanM., BeckettP. G., LathamL. K., SenfR., and GottliebJ. S.: The isolation of an active factor from serum of schizophrenic patients.Ann. N.Y. Acad. Sci.96: 438–477, 1962.
16.
FrohmanC. E., HarmisonC. R., ArthurC. R., and GottliebJ. S.: Conformation of a unique plasma protein in schizophrenia.Biol. Psychiatry3: 113–121, 1971.
17.
GabayS.: “Phenothiazines: neurochemical aspects of their mode of action.” In LajthaA., Ed. Handbook of Neurochemistry, Vol. 6, pp. 325–347. New York, Plenum Press, 1971.
18.
HeathR. G., and KruppI. M.: Schizophrenia as an immunologic disorder: I. Demonstration of antibrain globulins by fluorescent antibody techniques.Arch. Gen. Psychiatry.16: 1–9, 1967.
19.
HeathR. G., and KruppI. M.: Schizophrenia as an immunologic disorder: II. Effects of serum protein fractions on brain function.Arch. Gen. Psychiatry16: 10–23, 1967.
20.
HeathR. G., and KruppI. M.: Schizophrenia as an immunologic disorder: III. Effects of antimonkey and antihuman brain antibody on brain function.Arch. Gen. Psychiatry16: 24–33, 1967.
21.
LamoureuxG., BoulayG., and BorduasA. G.: A cytotoxic antibody for cultured nervous tissue in serum and cerebrospinal fluid from rhesus monkeys with allergic encephalomyelitis.Clin. Exp. Immunol.1: 307–321, 1966.
22.
MacPhersonC. F. C., and ShekR. P. N.: Effect of brain isoantibodies on learning and memory in the rat.Exp. Neurol.29: 1–15, 1970.
23.
MahlerH. R., and CordesE. H.: “Proteins: structure and properties.” In Biological Chemistry2nd Ed. pp. 42–109. New York, Harper and Row, 1971.
24.
MihalilovicL., and JankovicB. D.: Effects of intraventricularly injected and anti-N caudatus antibody on the electrical activity of the cat brain.Nature192: 665–666, 1961.
25.
NarasimhachariN., HellerB., SpaideJ., HaskovecL., MeitzerH., StrahilevitzM., and HimwichH. E.: N, N-dimethylated indoleamines in blood.Biol. Psychiatry3: 21–23, 1971.
26.
NarasimhachariN., PlautJ. M., and HimwichH. E.: Indolethylamine-N-methyltransferase in serum samples of schizophrenics and normal controls.Life Sci. (II)11: 221–227, 1972.
27.
NybäckH., and SedvallG.: Regional accumulation of catecholamines formed from tyrosine-14c in rat brain: effect of chlorpromazine.Europ. J. Pharmacol.5: 245–252, 1969.
28.
OzdemirA. I., and TannenbergA. M.: Peritoneal and hemodialysis for acute glutethimide overdosage.N.Y. State J. Med.72: 2076–2079, 1972.
29.
PatersonP. Y., and HarwinS. M.: Suppression of allergic encephalomyelitis in rats by means of anti-brain serum.J. Exp. Med.117: 755–774, 1963.
30.
PatonW. D. M.: “Receptors as defined by their pharmacological properties.” In PorterR., and O'ConnorM., Eds. Symposium on Molecular Properties of Drug-Receptors. A Ciba Foundation Symposium. pp. 3–32. London, J. & A. Churchill, 1970.
31.
RallD. P., OppletW. W., and PatlakC. S.: Extracellular space of brain as determined by diffusion of inulin from the ventricular system.Life Sci.1: 43–48, 1962.
32.
RanadiveN. S., and SehonA. H.: Antibodies to serotonin.Canad. J. Biochem.45: 1701–1710, 1967.
33.
RosenbaumJ. L., KramerM. S., RajaR., and BoreykoC.: Resin hemoperfusion: a new treatment for acute drug intoxication.N. Engl. J. Med.284: 874–877, 1971.
34.
RubinR. T.: Adrenal cortical activity changes in manic-depressive illness. Influence on intermediary metabolism of tryptophan.Arch. Gen. Psychiatry17: 671–679, 1967.
35.
SchmidtJ., and RaffertyM. A.: Purification of acetylcholine receptors from Torpedo californica eletroplax by affinity chromatography.Biochemistry12: 852–856, 1973.
36.
SelaM.: “Immunological studies with synthetic polypeptides.” In DexonF. J., and HumphreyJ. H. Eds. Advances in Immunology, Vol. 6. New York, Academic Press, 1966.
37.
SpectorS.: Application of immunology to neurochemisty.Adv. Biochem. Pharmacol.7: 181–190, 1969.
38.
SpectorS., and ParkerC. W.: Morphine: radioimmunoassay.Science168: 1327–1348, 1970.
39.
StanworthD. R., and ParodeG. I.: “Structural and biological characteristics of the immunoglobulins. In WeirD. M. Ed. Handbook of Experimental Immunology, pp. 134–328. Philadelphia, F. A. Davis, 1967.
40.
StrahilevitzM., NarasimhachariN., FujimoriM., and HimwichH. E.: Blocking of 5-methoxy-N-dimethyltryptamine-induced EEG alerting in the rabbit by previous administration of antiserum to this compound.Biol. Psychiatry3: 227–236, 1971.
41.
TourtellotteW. W.: Cerebrospinal fluid immunoglobulins and the central nervous system as an immunological organ particularly in multiple sclerosis and sub-acute sclerosing panencephalitis.Res. Publ. Assoc. Res. Nerv. Ment. Dis.49: 112–115, 1969.
42.
VanVunakisH., BradvicaH., BendaP., and LevineL.: Production and specificity of antibodies directed toward 3, 4, 5-trimethoxyphenylethylamine, 3, 4-dimethoxyphenylethylamine and 2, 5-dimethoxy-4methylamphetamine.Biochem. Pharmocol.18: 393–404, 1969.
43.
VanVunakisH., FarrowJ. T., GjikaH. B., and LevineL.: Specificity of the antibody receptor site to D-lysergamide: model of a physiological receptor for lysergic acid diethylamide.Proc. Natl. Acad. Sci. U.S.A.68: 1483–1487, 1971.
44.
VossE. W.Jr., and BergerB. B.: Neutralization of L.S.D. by active immunization.Psychopharmocologia26: 140–145, 1972.
45.
WainerB. H., FitchF. W., RothbergR. M., and SchusterC. R.: In vitro morphine antagonism by antibodies.Nature241: 537–538, 1973.
46.
WhittakerV. P.: “The subcellular fractionations of nervous tissue.” In BourneG. H. Ed. The Structure and Function of Nervous Tissue. pp. 1–24. New York, Academic Press, 1969.
47.
WyattR. J., SaavedraJ. M., and AxelrodJ.: A dimethyltryptamine-forming enzyme in human blood.Am. J. Psychiatry130: 754–760, 1973.